Global Facial Rejuvenation Market: Key Developments
Key players in the market are focused on establishing subsidiaries to expand their geographical presence. For instance, in October 2019, InMode Ltd. which is global provider of innovative, radiofrequency minimally and non-invasive medical technology, completed the establishment of two new subsidiaries in Asia Pacific - InMode India and InMode Australia.
In December 2019, Daewoong Pharmaceutical, a pharmaceutical company based in South Korea, received approval for its botulinum toxin product, Nabota, from The Ministry of Health in the U.A.E. and Indonesia’s Badan Pengawas Obat dan Makanan.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients